> [Original Message] > From: CDER MEDWATCH LISTSERV <[EMAIL PROTECTED]> > To: <[EMAIL PROTECTED]> > Date: 3/2/2007 4:06:48 PM > Subject: FDA - MedWatch - March 2007 FDA Patient Safety News is now available > > MedWatch - The FDA Safety Information and Adverse Event Reporting Program > > FDA Patient Safety News (PSN) is a monthly video news show for > healthcare professionals. It covers significant safety alerts, recalls, > new product approvals, and offers important tips on protecting patients. > Read the complete stories and watch or download the video program at > http://www.fda.gov/psn. You may have already received notification of > some of these safety issues through the MedWatch list serve. However, > many of these PSN stories contain video footage and > demonstrations that may be especially useful to educators in healthcare > facilities and academic institutions. > > Stories in the March 2007 edition include: > > New Cooling Device to Treat Infants with HIE > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#1 > > Thrombosis Associated with Coronary Drug-Eluting Stents > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#2 > > Serious Infection in Lupus Patients Treated with Rituxan > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#3 > > Expanded Recall/Market Withdrawal of Hernia Repair Patch > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#4 > > Precautions in Using Vapotherm Humidifier > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#5 > > New Safety Information on Trasylol > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#6 > > Possible Dose-Counter Errors with the Asmanex Twisthaler > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#7 > > Danger in Products Containing Quinine > http://www.accessdata.fda.gov/psn/transcript.cfm?show=61#8 > > _________________________________________________________________ > > To ensure delivery of these timely alerts to your in-box and prevent rejection of the notice by a spam filter, please add our MedWatch address, [EMAIL PROTECTED], to your address book. > > Thank you for using FDA MedWatch as a trusted source for timely safety information on drugs, devices and diagnostics regulated by the U.S. Food and Drug Administration. If you find this e-mail notification helpful, please consider telling colleagues and friends about MedWatch and this e-mail notification process. They can learn more and subscribe to the e-list at http://www.fda.gov/medwatch. > > To send a comment or question to the MedWatch program: http://www.fda.gov/medwatch/feedback.htm > > To unsubscribe from this listserve: > https://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1
